fluconazole has been researched along with Endocarditis in 73 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Endocarditis: Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery." | 8.82 | Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. ( Athan, E; Hughes, A; Lye, DC; O'Brien, D, 2005) |
| " On days 40 and 47, respectively, antifungal therapy was modified to liposomal Amphotericin B combined with Fluconazole 6 mg/kg/day for 4 weeks, resulting in complete resolution of the mycetomas." | 7.74 | Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates. ( Christofidou, M; Darzentas, A; Dimitriou, G; Giannakopoulos, I; Karatza, AA; Mantagos, SP; Marangos, M; Pavlou, V, 2008) |
| "An addicted, intravenous drug user was treated for Candida albicans tricuspid valve endocarditis with high dose fluconazole for 8 months, without relapse after 30 months." | 7.73 | Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole. ( Julander, I; Thalme, A; Westling, K, 2005) |
| "In vitro time-kill studies and a rabbit model of endocarditis and pyelonephritis were used to define the impact that the order of exposure of Candida albicans to fluconazole (FLC) and amphotericin B (AMB), as sequential and combination therapies, had on the susceptibility of C." | 7.71 | Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. ( Banerjee, P; Chen, G; Kaw, P; Liu, W; Louie, A; Miller, MH, 2001) |
| "We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis." | 7.70 | Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999) |
| "Amphotericin B (1 mg/kg of body weight, intravenous) and fluconazole (100 mg/kg, intraperitoneal) were compared in the prophylaxis of experimental Candida endocarditis caused by drug-susceptible, non-C." | 7.69 | Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Ghannoum, MA; Kim, E; Witt, MD, 1996) |
| "Amphotericin B (AmB) and fluconazole, administered intraperitoneally for 7 days, were compared in a rabbit model for Candida albicans endocarditis." | 7.69 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits. ( Carbon, C; Chemlal, K; Farinotti, R; Joly, V; Saint-Julien, L; Seta, N; Yeni, P, 1996) |
| "A case of active prosthetic valve infective endocarditis (PVE) due to Candida glabrata was successfully treated by the systemic administration of fluconazole." | 7.69 | The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case. ( Kawachi, Y; Maruyama, Y; Mayumi, H; Nakashima, A; Nishida, T; Tokunaga, K; Tokunaga, S; Yasui, H, 1994) |
| "An unusual case of catheter-related right-sided endocarditis, endophthalmitis, and extensive folliculitis, apparently caused by a single DNA biotype of Candida albicans, was successfully treated with a 6-month course of fluconazole plus two intravitreous doses of amphotericin B." | 7.68 | Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis. ( Cassone, A; Chirletti, P; De Bernardis, F; Martino, P; Micozzi, A; Pontieri, E; Venditti, M, 1992) |
| "Amphotericin B and fluconazole were compared for the treatment of experimental Candida endocarditis caused by Candida tropicalis and C." | 7.68 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Imhoff, T; Li, C; Witt, MD, 1993) |
| "Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery." | 4.82 | Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. ( Athan, E; Hughes, A; Lye, DC; O'Brien, D, 2005) |
| "The serum Fungitell assay was used to trend (1→3)-β-D-glucan in a patient with Candida endocarditis to determine treatment effectiveness with fluconazole, to provide an appropriate end date for antifungal therapy, and to survey infection suppression while off treatment." | 3.85 | (1→3)-β-D-Glucan Assay in Monitoring Response to Anti-Fungal Therapy in Fungal Endocarditis. ( Brown, M; Goldfarb, I; Johnson, T; Saling, C; Slim, J; Szabela, M, 2017) |
| " On days 40 and 47, respectively, antifungal therapy was modified to liposomal Amphotericin B combined with Fluconazole 6 mg/kg/day for 4 weeks, resulting in complete resolution of the mycetomas." | 3.74 | Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates. ( Christofidou, M; Darzentas, A; Dimitriou, G; Giannakopoulos, I; Karatza, AA; Mantagos, SP; Marangos, M; Pavlou, V, 2008) |
| " The patient has no identified sequelae at 6-month follow-up and continues on long-term fluconazole therapy for candida endocarditis." | 3.73 | Survival of candida sepsis in extracorporeal membrane oxygenation. ( Ibsen, LM; Minette, MS, 2005) |
| "An addicted, intravenous drug user was treated for Candida albicans tricuspid valve endocarditis with high dose fluconazole for 8 months, without relapse after 30 months." | 3.73 | Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole. ( Julander, I; Thalme, A; Westling, K, 2005) |
| "In vitro time-kill studies and a rabbit model of endocarditis and pyelonephritis were used to define the impact that the order of exposure of Candida albicans to fluconazole (FLC) and amphotericin B (AMB), as sequential and combination therapies, had on the susceptibility of C." | 3.71 | Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. ( Banerjee, P; Chen, G; Kaw, P; Liu, W; Louie, A; Miller, MH, 2001) |
| "We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis." | 3.70 | Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999) |
| "Amphotericin B (AmB) and fluconazole, administered intraperitoneally for 7 days, were compared in a rabbit model for Candida albicans endocarditis." | 3.69 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits. ( Carbon, C; Chemlal, K; Farinotti, R; Joly, V; Saint-Julien, L; Seta, N; Yeni, P, 1996) |
| "A case of active prosthetic valve infective endocarditis (PVE) due to Candida glabrata was successfully treated by the systemic administration of fluconazole." | 3.69 | The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case. ( Kawachi, Y; Maruyama, Y; Mayumi, H; Nakashima, A; Nishida, T; Tokunaga, K; Tokunaga, S; Yasui, H, 1994) |
| "Amphotericin B (1 mg/kg of body weight, intravenous) and fluconazole (100 mg/kg, intraperitoneal) were compared in the prophylaxis of experimental Candida endocarditis caused by drug-susceptible, non-C." | 3.69 | Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Ghannoum, MA; Kim, E; Witt, MD, 1996) |
| "An unusual case of catheter-related right-sided endocarditis, endophthalmitis, and extensive folliculitis, apparently caused by a single DNA biotype of Candida albicans, was successfully treated with a 6-month course of fluconazole plus two intravitreous doses of amphotericin B." | 3.68 | Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis. ( Cassone, A; Chirletti, P; De Bernardis, F; Martino, P; Micozzi, A; Pontieri, E; Venditti, M, 1992) |
| "Amphotericin B and fluconazole were compared for the treatment of experimental Candida endocarditis caused by Candida tropicalis and C." | 3.68 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Imhoff, T; Li, C; Witt, MD, 1993) |
| "Endophthalmitis is often treated with fluconazole or voriconazole, and the echinocandins are increasingly used, instead of amphotericin B, as initial therapy for osteomyelitis and endocarditis before step-down therapy to oral azole agents." | 2.52 | Complications of Candidemia in ICU Patients: Endophthalmitis, Osteomyelitis, Endocarditis. ( Kauffman, CA, 2015) |
| " However, successful therapy with long-term administration of oral fluconazole has been reported for five patients." | 2.39 | Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. ( Amidi, M; Keys, TF; McMahon, D; Nguyen, MH; Nguyen, ML; Yu, VL, 1996) |
| "Fungal endocarditis was confirmed by culturing of the resected vegetation showing mixed growth of Candida albicans and Candida tropicalis, although three consecutive blood cultures were negative for Candida species." | 1.39 | Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser. ( Abbasi, K; Anvari, MS; Badali, H; Boroumand, M; Fesharaki, SH; Haghani, I; Kargar, ML; Meis, JF; Mousavi, B, 2013) |
| "Candida endocarditis is extremely rare in term neonates, and gall bladder involvement due to candidemia has never been reported amongst neonates and infants." | 1.38 | Candida tropicalis infection in a term neonate with gall bladder masses and infective endocarditis. ( Garg, A; Goyal, VK; Jajoo, M; Kumar, V, 2012) |
| "Micafungin was started, patient responded, and fungemia cleared." | 1.36 | Candida kefyr endocarditis in a patient with hypertrophic obstructive cardiomyopathy. ( Afonso, L; Bhargava, A; Chopra, A; Chopra, T; Dhar, S; Kumar, S; Sobel, JD, 2010) |
| "Endocarditis is uncommon in infants and is exceptionally related to Candida albicans on pulmonary banding." | 1.35 | [Candida albicans endocarditis after pulmonary artery banding]. ( Acar, P; Dulac, Y; Kreitmann, B; Mansir, T; Paranon, S; Talvard, M, 2009) |
| "Endocarditis is an uncommon complication of invasive candidiasis." | 1.31 | Candida endocarditis in a premature infant. ( Mogyorósy, G; Nagy, A; Soós, G, 2000) |
| "Medical treatment of fungal endocarditis on prosthetic valves can be successful in selected cases." | 1.30 | A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone. ( Kozelj, M; Lejko-Zupanc, T, 1997) |
| "A 57-year-old male was treated for fungal endocarditis caused by Candida parapsilosis which precipitated severe cardiac valve vegetation and insufficiency." | 1.30 | A case report of Candida parapsilosis endocarditis. ( Inoue, Y; Kawada, S; Ueda, T; Yozu, R, 1998) |
| "Fungal endocarditis is considered an absolute indication for valve replacement surgery." | 1.29 | Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis. ( Hinthorn, DR; Klotz, SA; Zahid, MA, 1994) |
| "Aspergillus endocarditis has been considered as a fatal disease because of the difficulty of diagnosis and treatment." | 1.29 | [Two cases of Aspergillus endocarditis after cardiac surgery in childhood]. ( Kawasaki, S; Komai, Y; Naitoh, Y; Noguchi, Y; Takagaki, Y, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.37) | 18.7374 |
| 1990's | 24 (32.88) | 18.2507 |
| 2000's | 28 (38.36) | 29.6817 |
| 2010's | 19 (26.03) | 24.3611 |
| 2020's | 1 (1.37) | 2.80 |
| Authors | Studies |
|---|---|
| Sheikh, T | 1 |
| Tomcho, JC | 1 |
| Awad, MT | 1 |
| Zaidi, SR | 1 |
| Slim, J | 1 |
| Saling, C | 1 |
| Szabela, M | 1 |
| Brown, M | 1 |
| Johnson, T | 1 |
| Goldfarb, I | 1 |
| Rivoisy, C | 1 |
| Vena, A | 1 |
| Schaeffer, L | 1 |
| Charlier, C | 1 |
| Fontanet, A | 2 |
| Delahaye, F | 1 |
| Bouza, E | 2 |
| Lortholary, O | 2 |
| Munoz, P | 2 |
| Lefort, A | 2 |
| Ha, MV | 1 |
| Choy, MS | 1 |
| McCoy, D | 1 |
| Fernandez, N | 1 |
| Suh, JS | 1 |
| Siciliano, RF | 1 |
| Gualandro, DM | 1 |
| Sejas, ONE | 1 |
| Ignoto, BG | 1 |
| Caramelli, B | 1 |
| Mansur, AJ | 1 |
| Sampaio, RO | 1 |
| Pierrotti, LC | 1 |
| Barbosa, G | 1 |
| Golebiovski, W | 1 |
| Weksler, C | 1 |
| Lamas, C | 1 |
| Fortes, NRQ | 1 |
| Fortes, CQ | 1 |
| Tarasoutchi, F | 1 |
| Strabelli, TMV | 1 |
| Agnelli, C | 1 |
| Guinea, J | 1 |
| Valerio, M | 1 |
| Escribano, P | 1 |
| Hernández-Torres, A | 1 |
| García-Vázquez, E | 1 |
| Laso-Ortiz, A | 1 |
| Herrero-Martínez, JA | 1 |
| Gómez-Gómez, J | 1 |
| Fesharaki, SH | 1 |
| Haghani, I | 1 |
| Mousavi, B | 1 |
| Kargar, ML | 1 |
| Boroumand, M | 1 |
| Anvari, MS | 1 |
| Abbasi, K | 1 |
| Meis, JF | 1 |
| Badali, H | 1 |
| Garcia, J | 1 |
| Soch, K | 1 |
| Matthew, E | 1 |
| Surani, S | 1 |
| Horseman, MA | 1 |
| Anil Kumar, V | 1 |
| Francis, E | 1 |
| Sreehari, S | 1 |
| Raj, B | 1 |
| Gardiner, BJ | 1 |
| Slavin, MA | 1 |
| Korman, TM | 1 |
| Stuart, RL | 1 |
| Rivera, NT | 1 |
| Bray, N | 1 |
| Wang, H | 1 |
| Zelnick, K | 1 |
| Osman, A | 1 |
| Vicuña, R | 1 |
| Costa, A | 1 |
| Lahmers, S | 1 |
| Barry, SL | 1 |
| Stanton, J | 1 |
| Stern, JA | 1 |
| Toyoda, S | 1 |
| Tajima, E | 1 |
| Fukuda, R | 1 |
| Masawa, T | 1 |
| Inami, S | 1 |
| Amano, H | 1 |
| Arikawa, T | 1 |
| Yoshida, A | 1 |
| Hishinuma, A | 1 |
| Inoue, T | 1 |
| Bressieux-Degueldre, S | 1 |
| Sekarski, N | 1 |
| Di Bernardo, S | 1 |
| Kauffman, CA | 1 |
| Marti, J | 1 |
| Talvard, M | 1 |
| Paranon, S | 1 |
| Dulac, Y | 1 |
| Mansir, T | 1 |
| Kreitmann, B | 1 |
| Acar, P | 1 |
| Izumi, K | 1 |
| Hisata, Y | 1 |
| Hazama, S | 1 |
| Chopra, T | 1 |
| Bhargava, A | 1 |
| Kumar, S | 1 |
| Chopra, A | 1 |
| Dhar, S | 1 |
| Afonso, L | 1 |
| Sobel, JD | 1 |
| Smego, RA | 1 |
| Ahmad, H | 1 |
| Chartier, L | 1 |
| Sendid, B | 1 |
| Wolff, M | 1 |
| Mainardi, JL | 1 |
| Podglajen, I | 1 |
| Desnos-Ollivier, M | 1 |
| Bretagne, S | 1 |
| Jajoo, M | 1 |
| Kumar, V | 1 |
| Goyal, VK | 1 |
| Garg, A | 1 |
| Kaygusuz, I | 1 |
| Mulazimoglu, L | 1 |
| Cerikcioglu, N | 1 |
| Toprak, A | 1 |
| Oktay, A | 1 |
| Korten, V | 1 |
| Marchetti, O | 2 |
| Moreillon, P | 2 |
| Entenza, JM | 2 |
| Vouillamoz, J | 1 |
| Glauser, MP | 2 |
| Bille, J | 2 |
| Sanglard, D | 2 |
| Aaron, L | 1 |
| Therby, A | 1 |
| Viard, JP | 1 |
| Lahoulou, R | 1 |
| Dupont, B | 1 |
| Kaloterakis, A | 1 |
| Rizos, I | 1 |
| Goumas, G | 1 |
| Filiotou, A | 1 |
| Barbetseas, J | 1 |
| Papathanasiou, S | 1 |
| Toutouzas, P | 1 |
| Schelenz, S | 1 |
| Gransden, WR | 1 |
| Yeaman, MR | 1 |
| Cheng, D | 1 |
| Desai, B | 1 |
| Kupferwasser, LI | 1 |
| Xiong, YQ | 1 |
| Gank, KD | 1 |
| Edwards, JE | 1 |
| Bayer, AS | 4 |
| Prabhu, RM | 1 |
| Orenstein, R | 1 |
| del Castillo, M | 1 |
| Wainsztein, N | 1 |
| Klein, F | 1 |
| Manganello, S | 1 |
| Orellana, N | 1 |
| Nevado, J | 1 |
| De Alarcón, A | 1 |
| Hernández, A | 1 |
| Westling, K | 1 |
| Thalme, A | 1 |
| Julander, I | 1 |
| Hariya, A | 1 |
| Naruse, Y | 1 |
| Kobayashi, T | 1 |
| Endo, M | 1 |
| Ikeda, Y | 1 |
| Yoshii, T | 1 |
| Momomura, S | 1 |
| Ishiwata, S | 1 |
| Maehara, A | 1 |
| Minette, MS | 1 |
| Ibsen, LM | 1 |
| Lye, DC | 1 |
| Hughes, A | 1 |
| O'Brien, D | 1 |
| Athan, E | 1 |
| du Plessis, FA | 1 |
| Helbing, WA | 1 |
| Bogers, AJ | 1 |
| Salamon, SA | 1 |
| Fuursted, K | 1 |
| Egeblad, H | 1 |
| Petersen, E | 1 |
| Ott, P | 1 |
| Karatza, AA | 1 |
| Dimitriou, G | 1 |
| Marangos, M | 1 |
| Christofidou, M | 1 |
| Pavlou, V | 1 |
| Giannakopoulos, I | 1 |
| Darzentas, A | 1 |
| Mantagos, SP | 1 |
| Nishida, T | 1 |
| Mayumi, H | 1 |
| Kawachi, Y | 1 |
| Tokunaga, S | 1 |
| Maruyama, Y | 1 |
| Nakashima, A | 1 |
| Yasui, H | 1 |
| Tokunaga, K | 1 |
| Zahid, MA | 1 |
| Klotz, SA | 1 |
| Hinthorn, DR | 1 |
| Cancelas, JA | 1 |
| Lopez, J | 1 |
| Cabezudo, E | 1 |
| Navas, E | 1 |
| Garcia Laraña, J | 1 |
| Jimenez Mena, M | 1 |
| Diz, P | 1 |
| Perez de Oteyza, J | 1 |
| Villalon, L | 1 |
| Sanchez-Sousa, A | 1 |
| Witt, MD | 2 |
| Imhoff, T | 1 |
| Li, C | 1 |
| Czerwiec, FS | 1 |
| Bilsker, MS | 1 |
| Kamerman, ML | 1 |
| Bisno, AL | 1 |
| Wells, CJ | 1 |
| Leech, GJ | 1 |
| Lever, AM | 1 |
| Wansbrough-Jones, MH | 1 |
| Kawasaki, S | 1 |
| Naitoh, Y | 1 |
| Takagaki, Y | 1 |
| Komai, Y | 1 |
| Noguchi, Y | 1 |
| Chemlal, K | 1 |
| Saint-Julien, L | 1 |
| Joly, V | 2 |
| Farinotti, R | 1 |
| Seta, N | 1 |
| Yeni, P | 1 |
| Carbon, C | 2 |
| Fukui, T | 1 |
| Suehiro, S | 1 |
| Shibata, T | 1 |
| Sasaki, Y | 1 |
| Minamimura, H | 1 |
| Hattori, H | 1 |
| Kumano, H | 1 |
| Kishita, H | 1 |
| Kim, E | 1 |
| Ghannoum, MA | 2 |
| Nguyen, MH | 1 |
| Nguyen, ML | 1 |
| Yu, VL | 1 |
| McMahon, D | 1 |
| Keys, TF | 1 |
| Amidi, M | 1 |
| Sanati, H | 1 |
| Ramos, CF | 1 |
| Lejko-Zupanc, T | 1 |
| Kozelj, M | 1 |
| Inoue, Y | 1 |
| Yozu, R | 1 |
| Ueda, T | 1 |
| Kawada, S | 1 |
| Roel, JE | 1 |
| Gamba, A | 1 |
| Curone, M | 1 |
| Pescio, A | 1 |
| Bruno, C | 1 |
| Finquelievich, J | 1 |
| Ariffin, H | 1 |
| Ariffin, W | 1 |
| Tharam, S | 1 |
| Omar, A | 1 |
| de Bruyne, J | 1 |
| Lin, HP | 1 |
| Louie, A | 2 |
| Liu, W | 2 |
| Miller, DA | 1 |
| Sucke, AC | 1 |
| Liu, QF | 1 |
| Drusano, GL | 1 |
| Mayers, M | 1 |
| Miller, MH | 2 |
| Roger, PM | 1 |
| Boissy, C | 1 |
| Gari-Toussaint, M | 1 |
| Foucher, R | 1 |
| Mondain, V | 1 |
| Vandenbos, F | 1 |
| le Fichoux, Y | 1 |
| Michiels, JF | 1 |
| Dellamonica, P | 1 |
| Mogyorósy, G | 1 |
| Soós, G | 1 |
| Nagy, A | 1 |
| Kaw, P | 1 |
| Banerjee, P | 1 |
| Chen, G | 1 |
| Nurozler, F | 1 |
| Argenziano, M | 1 |
| Oz, MC | 1 |
| Naka, Y | 1 |
| Saito, Y | 1 |
| Takahashi, M | 1 |
| Sato, A | 1 |
| Katsuki, T | 1 |
| Ikeda, U | 1 |
| Shimada, K | 1 |
| Liang, JD | 1 |
| Fang, CT | 1 |
| Chen, YC | 1 |
| Chang, SC | 1 |
| Luh, KT | 1 |
| Posteraro, B | 1 |
| Valentini, P | 1 |
| Delogu, A | 1 |
| De, RG | 1 |
| Boccacci, S | 1 |
| Sanguinetti, M | 1 |
| Nacci, A | 1 |
| Sopo, SM | 1 |
| Ranno, O | 1 |
| Morace, G | 1 |
| Fadda, G | 1 |
| Jones, JM | 1 |
| Sarsam, MA | 1 |
| Clarke, MA | 1 |
| Hedderwick, SA | 1 |
| Hernández, JA | 1 |
| Gonzalez-Moreno, M | 1 |
| Llibre, JM | 1 |
| Aloy, A | 1 |
| Casan, CM | 1 |
| Venditti, M | 1 |
| De Bernardis, F | 1 |
| Micozzi, A | 1 |
| Pontieri, E | 1 |
| Chirletti, P | 1 |
| Cassone, A | 2 |
| Martino, P | 2 |
| Yamamoto, W | 1 |
| Ino, T | 1 |
| Sakurabayashi, I | 1 |
| Ide, H | 1 |
| Yaginuma, T | 1 |
| Martinez-Lacasa, J | 1 |
| Maña, J | 1 |
| Niubó, R | 1 |
| Rufi, G | 1 |
| Saez, A | 1 |
| Fernández-Nogués, F | 1 |
| Roupie, E | 1 |
| Darmon, JY | 1 |
| Brochard, L | 1 |
| Saada, M | 1 |
| Rekik, N | 1 |
| Brun-Buisson, C | 1 |
| Meloni, G | 1 |
| Isalska, BJ | 1 |
| Stanbridge, TN | 1 |
9 reviews available for fluconazole and Endocarditis
| Article | Year |
|---|---|
[Candida sp endocarditis. Experience in a third-level hospital and review of the literature].
Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacteria | 2013 |
Rare infection of implantable cardioverter-defibrillator lead with Candida albicans: case report and literature review.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Defibrillators, Implantable; Echinocandins; Echoca | 2014 |
Complications of Candidemia in ICU Patients: Endophthalmitis, Osteomyelitis, Endocarditis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Echinocandins; Echocardiography; Endocarditi | 2015 |
The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidemia; Candidiasis; Dose-R | 2011 |
Isolated native tricuspid valve Candida endocarditis in a non-drug-addicted patient: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Debridement; Echocardiography; Endocarditis; Flucona | 2003 |
Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Caspofu | 2005 |
[Successful surgical treatment for fungal endocarditis involving the aortic valve: report of a case].
Topics: Antifungal Agents; Aortic Valve; Aortic Valve Insufficiency; Combined Modality Therapy; Endocarditis | 1996 |
Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; H | 1996 |
Successful treatment of Candida albicans endocarditis in a child with leukemia--a case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child, Preschool; Drug Therapy, Combination; Endocar | 1999 |
64 other studies available for fluconazole and Endocarditis
| Article | Year |
|---|---|
Topics: Administration, Intravenous; Aftercare; Aged, 80 and over; Antifungal Agents; Aortic Valve; Candida | 2020 |
(1→3)-β-D-Glucan Assay in Monitoring Response to Anti-Fungal Therapy in Fungal Endocarditis.
Topics: Aged; Antifungal Agents; beta-Glucans; Biomarkers; Candida glabrata; Candidiasis; Drug Monitoring; E | 2017 |
Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Disease Management; Endocarditis; Fem | 2018 |
Candida catenulata Candidaemia and Possible Endocarditis in a Cirrhotic Patient Successfully De-escalated to Oral Fluconazole.
Topics: Abdominal Pain; Administration, Oral; Adult; Antifungal Agents; Candida; Candidemia; Endocarditis; F | 2018 |
Outcomes in patients with fungal endocarditis: A multicenter observational cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Echinocandins; Endocarditis; Female; Fluconazole; | 2018 |
Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
Topics: Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echino | 2019 |
Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Candidiasis; Coinfec | 2013 |
Endocarditis caused by Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Endocarditis; Fluconazole; H | 2013 |
Tricuspid valve mycetoma in an infant successfully treated by excision and complex tricuspid valve repair followed by fluconazole therapy.
Topics: Antifungal Agents; Candida; Candidiasis; Endocarditis; Fluconazole; Humans; Infant; Male; Mycetoma; | 2014 |
Hampered by historical paradigms--echinocandins and the treatment of Candida endocarditis.
Topics: Anidulafungin; Antifungal Agents; Candida; Echinocandins; Endocarditis; Fluconazole; Humans; Male; M | 2014 |
Fungal pericarditis and endocarditis secondary to porcupine quill migration in a dog.
Topics: Animals; Antifungal Agents; Dog Diseases; Dogs; Endocarditis; Fluconazole; Foreign Bodies; Male; Myc | 2014 |
Early surgical intervention and optimal medical treatment for Candida parapsilosis endocarditis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aortic Valve; Candida; Candidiasis; Endocarditis; Fluconazo | 2015 |
Fungal endocarditis after hybrid periventricular closure of muscular ventricular septal defect by Amplatzer occluder in a child.
Topics: Administration, Oral; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Endocarditis; Fluco | 2015 |
Candida parapsilosis endocarditis in aged patient.
Topics: Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Endocarditis; | 2009 |
[Candida albicans endocarditis after pulmonary artery banding].
Topics: Administration, Oral; Aneurysm, False; Aneurysm, Infected; Antifungal Agents; Candidiasis; Caspofung | 2009 |
A rare case of infective endocarditis complicated by Trichosporon asahii fungemia treated by surgery.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aortic Valve; Combined Modality Therapy; Echocardiography; | 2009 |
Candida kefyr endocarditis in a patient with hypertrophic obstructive cardiomyopathy.
Topics: Aged; Antifungal Agents; Candidiasis; Cardiomyopathy, Hypertrophic; Echinocandins; Endocarditis; Fem | 2010 |
Diagnosis, management and outcome of Candida endocarditis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Anti | 2012 |
Candida tropicalis infection in a term neonate with gall bladder masses and infective endocarditis.
Topics: Amphotericin B; Antifungal Agents; Candida tropicalis; Candidiasis; Endocarditis; Fluconazole; Gallb | 2012 |
An unusual native tricuspid valve endocarditis caused by Candida colliculosa.
Topics: Aged; Amphotericin B; Candida; Candidiasis; Endocarditis; Fluconazole; Humans; Male; Tricuspid Valve | 2003 |
Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Tra | 2003 |
Successful medical treatment of Candida albicans in mechanical prosthetic valve endocarditis.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Therapy, Combination; E | 2003 |
Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period.
Topics: Antifungal Agents; Brain Abscess; Candidiasis; Cross Infection; Drug Resistance, Fungal; Endocarditi | 2003 |
Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans.
Topics: Animals; Antifungal Agents; Blood Proteins; Candida albicans; Candidiasis; Colony Count, Microbial; | 2004 |
Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Abscess; Candida albicans; Candidiasis; Caspofungin; | 2004 |
[Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
Topics: Aged; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echi | 2004 |
Caspofungin: a new therapeutic option for fungal endocarditis.
Topics: Adult; Antifungal Agents; Candidiasis; Caspofungin; Echinocandins; Endocarditis; Fluconazole; Humans | 2005 |
Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Diseases; Humans; Mid | 2005 |
[Fungal endocarditis found at onset of lower limb acute aortic occlusion; report of a case].
Topics: Acute Disease; Antifungal Agents; Aortic Diseases; Arterial Occlusive Diseases; Candidiasis; Combine | 2005 |
Survival of candida sepsis in extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Endocarditis; Extracorporeal Memb | 2005 |
Excision of the tricuspid valve in a baby with Candida endocarditis.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Failure; Humans; Infant; Ni | 2007 |
Candida albicans tricuspid and pulmonic valve endocarditis: challenge of relapsing risk and role of combined medical treatment and surgery.
Topics: Adult; Candida albicans; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Diseases; Heart | 2007 |
Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Endocarditis; Female; Fluconazole | 2008 |
The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case.
Topics: Aged; Aortic Valve Insufficiency; Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Hu | 1994 |
Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Endocarditis; Fluconazole; Fungemia; Heart V | 1994 |
Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Endocarditis; Female; Fluc | 1994 |
Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Endocarditis; Female; Fluconazole; Heart; Injections, | 1993 |
Long-term survival after fluconazole therapy of candidal prosthetic valve endocarditis.
Topics: Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Male; Middle Aged; Prosthesi | 1993 |
Treatment of native valve Candida endocarditis with fluconazole.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Follow-Up Studies; Heart Valve Di | 1995 |
[Two cases of Aspergillus endocarditis after cardiac surgery in childhood].
Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Endocarditis; Female; Fluconazole; Humans; Male; | 1996 |
Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Endocarditis; Fluc | 1996 |
Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Administration Schedule; Endocarditis; | 1996 |
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; D | 1997 |
A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prost | 1997 |
A case report of Candida parapsilosis endocarditis.
Topics: Antifungal Agents; Aortic Valve; Aortic Valve Stenosis; Candidiasis; Catheterization, Central Venous | 1998 |
[Successful medical treatment of Candida tropicalis in prosthetic valve endocarditis].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prost | 1998 |
Unfortunate in vitro selection of resistant Candida albicans with severe clinical consequences.
Topics: Amphotericin B; Animals; Antifungal Agents; Aortic Valve; Aortic Valve Insufficiency; Candida albica | 1998 |
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Endocarditis; | 1999 |
Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candidiasis; Endocarditis; Fa | 2000 |
Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cyclosporine; Disease Models, Animal; Dru | 2000 |
Candida endocarditis in a premature infant.
Topics: Candida albicans; Candidiasis; Endocarditis; Fatal Outcome; Fluconazole; Humans; Infant, Newborn; In | 2000 |
Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Endocarditis; Flucon | 2001 |
Fungal left ventricular assist device endocarditis.
Topics: Amphotericin B; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Endocarditis; | 2001 |
Isolated tricuspid valve endocarditis due to Candida parapsilosis associated with long-term central venous catheter implantation.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Echocardiogra | 2001 |
Candida albicans spinal epidural abscess secondary to prosthetic valve endocarditis.
Topics: Amphotericin B; Candida albicans; Candidiasis; Endocarditis; Epidural Abscess; Female; Fluconazole; | 2001 |
Candida albicans endocarditis diagnosed by PCR-based molecular assay in a critically ill pediatric patient.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Child, Preschool; Critical Illness; Down Syndrome; | 2002 |
Candida parapsilosis: two cases of endocarditis in association with the Toronto stentless porcine valve.
Topics: Aged; Aged, 80 and over; Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Endocardi | 2002 |
Candidal mitral endocarditis and long-term treatment with fluconazole in a patient with human immunodeficiency virus infection.
Topics: Adult; Candidiasis; Endocarditis; Female; Fluconazole; HIV Infections; Humans | 1992 |
Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis.
Topics: Adult; Antibodies, Fungal; Antigens, Fungal; Candida albicans; Candidiasis; DNA Fingerprinting; DNA, | 1992 |
[A case of Candida albicans endocarditis with impaired lung function].
Topics: Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Lung Diseases; Male; Middle | 1992 |
Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii.
Topics: Amphotericin B; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mycose | 1991 |
Fluconazole therapy of candidal native valve endocarditis.
Topics: Candidiasis; Endocarditis; Fluconazole; Humans; Lung Diseases, Obstructive; Male; Middle Aged | 1991 |
Candidal endocarditis and treatment with fluconazole and granulocyte-macrophage colony-stimulating factor.
Topics: Adult; Candidiasis; Colony-Stimulating Factors; Drug Therapy, Combination; Endocarditis; Fluconazole | 1990 |
Fluconazole in the treatment of candidal prosthetic valve endocarditis.
Topics: Adult; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prosthesis; Humans; Mitral Valve; | 1988 |